An entropically efficient supramolecular inhibition strategy for Shiga toxins.
D000818:Animals; D001665:Binding Sites; D002236:Carbohydrate Conformation; D002240:Carbohydrate Sequence; D016923:Cell Death / Q000187:drug effects; D002522:Chlorocebus aethiops; D015195:Drug Design; D019277:Entropy; D005990:Glycerol / Q000737:chemistry; D006801:Humans; D008024:Ligands; D046911:Macromolecular Substances / Q000037:antagonists & inhibitors / Q000737:chemistry; D051379:Mice; D008822:Mice, Transgenic; D008958:Models, Molecular; D008969:Molecular Sequence Data; D008970:Molecular Weight; D011773:Pyruvates / Q000737:chemistry; D000683:Serum Amyloid P-Component / Q000037:antagonists & inhibitors* / Q000737:chemistry; D022622:Shiga Toxin 1 / Q000037:antagonists & inhibitors* / Q000737:chemistry; D022641:Shiga Toxin 2 / Q000037:antagonists & inhibitors* / Q000737:chemistry; D014312:Trisaccharides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D014709:Vero Cells
D008024:Ligands; D046911:Macromolecular Substances; D011773:Pyruvates; D000683:Serum Amyloid P-Component; D022622:Shiga Toxin 1; D022641:Shiga Toxin 2; D014312:Trisaccharides; D005990:Glycerol